BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 25114851)

  • 1. Main controversies in breast cancer.
    Zervoudis S; Iatrakis G; Tomara E; Bothou A; Papadopoulos G; Tsakiris G
    World J Clin Oncol; 2014 Aug; 5(3):359-73. PubMed ID: 25114851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevention, detection, and management of breast cancer.
    Houssami N; Cuzick J; Dixon JM
    Med J Aust; 2006 Mar; 184(5):230-4. PubMed ID: 16515434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contralateral lymph node metastasis in recurrent ipsilateral breast cancer with Lynch syndrome: a locoregional event.
    Zwimpfer TA; Schwab FD; Steffens D; Kaul F; Schmidt N; Geiger J; Geissler F; Heinzelmann-Schwarz V; Weber WP; Kurzeder C
    World J Surg Oncol; 2023 Feb; 21(1):40. PubMed ID: 36755294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responding to the challenges of breast cancer in egypt and other arab countries.
    El Saghir NS
    J Egypt Natl Canc Inst; 2008 Dec; 20(4):309-12. PubMed ID: 20571588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axillary node interventions in breast cancer: a systematic review.
    Rao R; Euhus D; Mayo HG; Balch C
    JAMA; 2013 Oct; 310(13):1385-94. PubMed ID: 24084924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Needle aspiration cytology of the breast: current perspective on the role in diagnosis and management].
    Kocjan G
    Acta Med Croatica; 2008 Oct; 62(4):391-401. PubMed ID: 19205416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial.
    de Boniface J; Frisell J; Andersson Y; Bergkvist L; Ahlgren J; Rydén L; Olofsson Bagge R; Sund M; Johansson H; Lundstedt D;
    BMC Cancer; 2017 May; 17(1):379. PubMed ID: 28549453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel node biopsy in conservative surgery for breast cancer: a changing role in clinical practice.
    Magnoni F; Veronesi P
    Minerva Chir; 2020 Dec; 75(6):386-391. PubMed ID: 32975389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical management of early stage invasive breast cancer: a practice guideline.
    McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
    Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between outcome and extent of residual disease in the sentinel node after neoadjuvant chemotherapy in clinically fine-needle proven node-positive breast cancer patients.
    Canavese G; Tinterri C; Carli F; Garrone E; Spinaci S; Della Valle A; Barbieri E; Marrazzo E; Bruzzi P; Dozin B
    Eur J Surg Oncol; 2021 Aug; 47(8):1920-1927. PubMed ID: 33972144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
    Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
    Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Relevance of Ultrasound Imaging of Suspicious Axillary Lymph Nodes and Fine-needle Aspiration Biopsy in the Post-ACOSOG Z11 Era in Early Breast Cancer.
    Vijayaraghavan GR; Vedantham S; Kataoka M; DeBenedectis C; Quinlan RM
    Acad Radiol; 2017 Mar; 24(3):308-315. PubMed ID: 27916595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy.
    Kang YJ; Han W; Park S; You JY; Yi HW; Park S; Nam S; Kim JH; Yun KW; Kim HJ; Ahn SH; Park S; Lee JE; Lee ES; Noh DY; Lee JW
    Breast Cancer Res Treat; 2017 Nov; 166(2):473-480. PubMed ID: 28766131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel Node Biopsy in Patients With Breast Carcinoma Without Axillary Involvement at Diagnosis Receiving Primary Systemic Therapy.
    García-Calvo L; Martí Álvarez C; Gutiérrez AH; García AB; Muñoz RA; Sánchez-Méndez JI
    Clin Breast Cancer; 2023 Aug; 23(6):672-679. PubMed ID: 37331894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary Nodal Burden in Breast Cancer Patients With Pre-operative Fine Needle Aspiration-proven Positive Lymph Nodes Compared to Those With Positive Sentinel Nodes.
    Cipolla C; Valerio MR; Grassi N; Calamia S; Latteri S; Latteri M; Graceffa G; Vieni S
    In Vivo; 2020; 34(2):729-734. PubMed ID: 32111777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current surgical management of breast cancer.
    Cody HS
    Curr Opin Obstet Gynecol; 2002 Feb; 14(1):45-52. PubMed ID: 11801876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost/accuracy ratio analysis in breast cancer patients undergoing ultrasound-guided fine-needle aspiration cytology, sentinel node biopsy, and frozen section of node.
    Genta F; Zanon E; Camanni M; Deltetto F; Drogo M; Gallo R; Gilardi C
    World J Surg; 2007 Jun; 31(6):1155-63. PubMed ID: 17464539
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.